AXA SA

Report azionario ENXTPA:CS

Capitalizzazione di mercato: €87.4b

AXA Crescita futura

Criteri Future verificati 2/6

AXA prevede che gli utili e i ricavi cresceranno rispettivamente di 6.2% e 7.9% all'anno. Si prevede che l'EPS crescerà di 7.8% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 17.8% in 3 anni.

Informazioni chiave

6.2%

Tasso di crescita degli utili

7.81%

Tasso di crescita dell'EPS

Insurance crescita degli utili5.5%
Tasso di crescita dei ricavi7.9%
Rendimento futuro del capitale proprio17.84%
Copertura analitica

Good

Ultimo aggiornamento11 Sep 2026

Aggiornamenti recenti sulla crescita futura

Recent updates

Aggiornamento narrativa • Sep 03

CS: Higher Earnings Multiple Will Be Supported By AI Governance Progress

Analysts have lifted the fair value estimate for AXA to €66.18 from €64.68, reflecting higher Street price targets that now reach up to €77.10 as they point to updated assumptions on revenue growth, profit margins and future P/E multiples. Analyst Commentary Recent Street research on AXA points to a cluster of higher price targets and supportive ratings that highlight constructive views on the stock.
Aggiornamento narrativa • Aug 13

CS: Raised Price Views Will Support A Higher Future Earnings Multiple

AXA’s updated analyst price target has risen to €64.68 from €62.41. This reflects adjustments in fair value, discount rate, revenue growth, profit margin and future P/E that are broadly consistent with recent target increases from several research firms.
Aggiornamento narrativa • Jul 30

CS: Higher Revenue Assumptions And Lower Discount Rate Will Test Execution

AXA's analyst price target has increased to €42.40 from €40.00, with analysts citing updated assumptions for revenue growth, margins, P/E and discount rates that are broadly consistent with recent upward revisions to Street targets in the range of approximately €50 to €77.10 per share. Analyst Commentary Recent Street research on AXA shows a wide spread in price targets, ranging from around €50 to €77.10 per share.
Aggiornamento narrativa • Jul 16

CS: Updated Fair Value And P/E Assumptions Will Shape Balanced Re Rating

AXA's analyst price target has been nudged higher to €50, with analysts pointing to slightly adjusted fair value estimates, updated revenue growth and margin assumptions, and modestly refined future P/E expectations as key factors supporting the change. Analyst Commentary Recent research commentary on AXA points to a mixed but generally constructive view, with several price target increases and one reduction reflecting different opinions on valuation, growth assumptions, and execution risk.
Nuova narrativa • Jun 30

Climate And Aging Trends Will Shape Insurance Demand While Returns Stay Steady

Catalysts About AXA AXA is a global insurance group offering property and casualty, life, health, savings and retirement products to retail clients, businesses and institutions. What are the underlying business or industry changes driving this perspective?
Aggiornamento narrativa • Jun 18

CS: Higher Fair Value And P/E Assumptions Will Support Measured Re Rating

Analysts have nudged the fair value estimate for AXA higher to €47.51 from €46.48, citing a series of upward revisions to price targets, including recent increases to around €77.10 from €57.40 and by €1 in other Street updates, alongside broadly supportive new coverage. Analyst Commentary Recent Street research on AXA offers a mix of optimism and caution that investors can weigh against the revised fair value estimate.
Nuova narrativa • Jun 15

AI And Climate Risk Tailwinds Will Reshape This Global Insurer’s Next Decade

Catalysts About AXA AXA is a global insurance group active in Property & Casualty, Life, Health, Savings and reinsurance across Europe, Asia, Africa and other markets. What are the underlying business or industry changes driving this perspective?
Aggiornamento narrativa • Jun 03

CS: Higher Fair Value And P/E Assumptions Will Support Measured Re Rating

AXA's analyst price target has edged higher by about €0.35, with analysts pointing to modestly revised assumptions around fair value, discount rate, profit margin and future P/E. This move is supported by recent research that includes both a €1 target increase and a €1 reduction from different banks, alongside a bullish initiation.
Aggiornamento narrativa • May 08

CS: Technical And Fee-Based Shift Plus Buybacks Will Support Measured Re-Rating

AXA's fair value estimate edges higher to €46.12 from €46.07 as analysts refine assumptions around revenue growth, profit margins and future P/E, supported by a series of recent price target increases and bullish initiations on the stock. Analyst Commentary Recent Street research around AXA has been active, with several price target revisions and fresh initiations feeding into the updated fair value estimate.
Aggiornamento narrativa • Apr 22

CS: Technical And Fee-Based Earnings Mix Will Support Re-Rating As Discount Persists

Analysts have nudged their average price target for AXA slightly higher to about €46.07. This reflects modest tweaks to assumptions around discount rates, profit margins and future P/E multiples, alongside recent Street research that includes both upward and downward target revisions clustered around the €46 to €50 range.
Aggiornamento narrativa • Apr 07

CS: Technical And Fee-Based Earnings Shift Will Support Re-Rating As Discount Persists

AXA's analyst price targets have edged higher into a €46 to €50.70 range, as analysts point to improved profitability from technical insurance and fee-based earnings, along with what they view as an ongoing discount to European composite peers. Analyst Commentary Recent research points to a cluster of higher price targets for AXA, with analysts largely focused on the mix of technical insurance and fee-based earnings and how that feeds into profitability, earnings stability, and valuation relative to European peers.
Aggiornamento narrativa • Mar 24

CS: Technical And Fee-Based Shift Will Support Re-Rating As Discount Persists

Analysts have nudged AXA's average price target higher to around €48 to €51, citing improved profitability from its focus on technical insurance and fee-based earnings and pointing out that the current valuation still sits at a discount to European composite peers. Analyst Commentary Recent Street research has tilted positive on AXA, with several banks lifting their price targets into a relatively tight band between €46 and about €51.
Aggiornamento narrativa • Mar 10

CS: Technical And Fee-Based Shift Will Support Re-Rating Versus European Composite Peers

Our AXA fair value estimate has been adjusted from €45.27 to €46.05. This reflects higher analyst price targets in the €46 to €50.70 range and their focus on improved profitability, lower earnings volatility and a reduced P/E assumption.
Aggiornamento narrativa • Feb 23

CS: Technical And Fee-Based Shift Will Support Higher Future Earnings Multiple

Analysts have nudged their price target for AXA slightly higher to about €45.27 from roughly €45.11, citing continued focus on technical insurance and fee-based earnings that they say is supporting improved profitability and a higher assumed future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts point to the shift towards technical insurance and fee-based earnings as a key support for more stable and higher quality profit streams, which they see as supportive of a stronger P/E multiple over time.
Aggiornamento narrativa • Feb 08

CS: Slightly Lower Discount Rate Will Support Forward Earnings Appeal

The analyst fair value estimate for AXA has been adjusted slightly higher to €45.11 from €45.06, as analysts refine their assumptions around discount rates, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value Estimate adjusted slightly higher to €45.11 from €45.06.
Aggiornamento narrativa • Jan 24

CS: Stable Assumptions And Slightly Higher Required Return Will Support Forward Earnings Appeal

Analysts have slightly raised their fair value estimate for AXA to €45.06 from €44.98, citing adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E that together support a marginally higher price target. Valuation Changes Fair value estimate is now set at €45.06, up slightly from €44.98, reflecting a very small adjustment in the model.
Aggiornamento narrativa • Jan 10

CS: Stable Assumptions And Slightly Lower P/E Will Support Forward Earnings Appeal

Analysts have reduced their price target for AXA slightly to about €45, reflecting small adjustments to fair value estimates, discount rate assumptions and future P/E expectations, while keeping revenue growth and profit margin forecasts broadly unchanged. Valuation Changes Fair Value: Adjusted slightly from €45.07 to €44.98, indicating a very small reduction in the estimated fair value per share.
Aggiornamento narrativa • Dec 17

CS: Lower Discount Rate Will Support Stronger Forward Earnings Appeal

Analysts have nudged their price target on AXA slightly higher to approximately €45.07 from about €45.04, citing a marginally lower discount rate and modest improvements in projected profit margins that together support a slightly richer valuation multiple. Valuation Changes Fair Value has risen slightly from approximately €45.04 to about €45.07, reflecting a marginal uplift in the intrinsic valuation estimate.
Aggiornamento narrativa • Dec 03

CS: Modestly Higher Future Multiple Will Support Attractive Upside Potential

Analysts have modestly raised their price target on AXA to €45.04, citing a slightly higher assumed future price to earnings multiple, which more than offsets marginal adjustments to the discount rate and profit margin forecasts. Valuation Changes Fair Value Estimate unchanged at approximately €45.04 per share, indicating no revision to the intrinsic value assessment.
Aggiornamento narrativa • Nov 19

CS: Strong Profit Margins And Stable P/E Will Drive Future Gains

Analysts have slightly raised their price target for AXA, increasing it from €44.96 to €45.04. This change is based on modest adjustments to projected revenue growth, profit margins, and discount rates.
Aggiornamento narrativa • Nov 02

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

Analysts have slightly raised their price target for AXA from €44.58 to €44.96, citing incremental improvements in profit margin and expected future earnings multiples as key factors supporting the revision. Valuation Changes Fair Value has increased slightly from €44.58 to €44.96.
User avatar
Nuova narrativa • Nov 07

Calculated Market Expansion And Innovative Products Drive Revenue Growth And Profitability

AXA's disciplined pricing and focus on operational excellence aim to enhance profitability in international markets.

Previsioni di crescita degli utili e dei ricavi

ENXTPA:CS - Stime future degli analisti e dati finanziari passati (EUR Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/2028124,7849,4438,9006,3994
12/31/2027119,2319,0007,1786,3584
12/31/2026113,8228,4216,8096,3594
6/30/202696,7947,65414,50114,920N/A
3/31/202695,7437,46418,37218,795N/A
12/31/202594,6917,27422,24222,670N/A
9/30/202593,9517,20321,37321,822N/A
6/30/202593,2117,13220,50320,974N/A
3/31/202592,2337,13115,95316,426N/A
12/31/202491,2557,13011,40211,878N/A
9/30/202486,1837,431N/AN/AN/A
6/30/202488,5706,6405,9276,392N/A
3/31/202487,1446,6544,7505,192N/A
12/31/202385,7176,6673,5733,992N/A
9/30/202386,1925,9327,2507,673N/A
6/30/202385,2334,8599,1619,580N/A
3/31/202386,0134,8698,7349,143N/A
12/31/202286,7934,8798,3078,705N/A
9/30/202295,6915,9205,3835,737N/A
6/30/2022104,5886,9612,4592,769N/A
3/31/2022113,3807,0314,3184,648N/A
12/31/2021122,1717,1006,1766,526N/A
9/30/2021121,9056,32411,48411,872N/A
6/30/2021121,6395,54816,79217,217N/A
3/31/2021116,9934,26820,96921,376N/A
12/31/2020112,3472,98725,14525,534N/A
6/30/2020110,2322,76919,74220,137N/A
3/31/2020121,6713,198N/A14,482N/A
12/31/2019133,1093,627N/A8,827N/A
6/30/2019124,0371,822N/A5,029N/A
3/31/2019115,2312,064N/A6,332N/A
12/31/2018106,4252,306N/A7,634N/A
9/30/2018114,7093,694N/A9,704N/A
6/30/2018123,0105,509N/A11,773N/A
3/31/2018127,8015,745N/A14,149N/A
12/31/2017132,5925,980N/A16,525N/A
9/30/2017131,8615,831N/AN/AN/A
6/30/2017131,1295,682N/A15,904N/A
3/31/2017129,0805,842N/A14,722N/A
12/31/2016127,0316,001N/A13,539N/A
9/30/2016120,9085,912N/AN/AN/A
6/30/2016114,7845,823N/A16,396N/A
3/31/2016115,1215,536N/A17,311N/A
12/31/2015115,4585,248N/A18,226N/A
9/30/2015119,6565,001N/AN/AN/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di CS ( 6.2% all'anno) è superiore al tasso di risparmio ( 2.6% ).

Guadagni vs Mercato: Si prevede che gli utili di CS ( 6.2% all'anno) cresceranno più lentamente rispetto al mercato French ( 12.8% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di CS cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di CS ( 7.9% all'anno) crescerà più rapidamente del mercato French ( 5.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di CS ( 7.9% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di CS sarà basso tra 3 anni ( 17.8 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/09/13 18:36
Prezzo dell'azione a fine giornata2026/09/11 00:00
Utili2026/06/30
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.

Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

AXA SA è coperta da 34 analisti. 13 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Markus MayerBaader Helvea Equity Research
null nullBanco de Sabadell. S.A.
Valvanera Gómez PastorBanco Santander